MBX BIOSCIENCES INC
MBX · NASDAQ
Updated at 2026-10-13 14:27:43
- Today's High
- $53.04
- Today’s Low
- $51.30
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $53.24
- Previous Close
- $52.02
- Volume
- 991.56K
- Market Cap
- $2.5B
- P/E Ratio
- --
- EPS
- $-2.40
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 11711 NORTH MERIDIAN STREET, CARMEL, IN, UNITED STATES, 46032
- Country
- US
- Listing Date
- 2024-09-13
- Fiscal Year End
- December
- Shares Outstanding
- 47.6M
- CIK
- 0001776111
- Website
- mbxbio.com
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. The company is headquartered in Carmel, Indiana.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$40.93M
2026-03-31
$27.26M
2025-12-31
$25.79M
2025-09-30
$23.92M
Net Income
2026-06-30
-$37.09M
2026-03-31
-$23.51M
2025-12-31
-$22.06M
2025-09-30
-$21.61M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.78
2026-03-31
$-0.51
2025-12-31
$-0.49
2025-09-30
$-0.63
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$40.85M
2026-03-31
-$23.45M
2025-12-31
-$22M
2025-09-30
-$21.56M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $40.93M | $27.26M | $25.79M | $23.92M |
| Net Income | -$37.09M | -$23.51M | -$22.06M | -$21.61M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.78 | $-0.51 | $-0.49 | $-0.63 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$40.85M | -$23.45M | -$22M | -$21.56M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.